September 9 2020 Launch of MISTI, a modular platform for instruments

About us
Products
News
- Events
  - No product available in your country for now.
    Please contact us for more information
    Contact us
- Press releases
  - No product available in your country for now.
    Please contact us for more information
    Contact us
- Blog
  - No product available in your country for now.
    Please contact us for more information
    Contact us
Careers
Investors
- Schedule
  - No product available in your country for now.
    Please contact us for more information
    Contact us
- Share price
  - No product available in your country for now.
    Please contact us for more information
    Contact us
- Regulated information
  - No product available in your country for now.
    Please contact us for more information
    Contact us
- nav.investors_press_release
  - No product available in your country for now.
    Please contact us for more information
    Contact us
Contact

Spineway, specialized in the treatment of severe disorders of the spine, announces the launch of a new concept: MISTI (acronym for Minimally Invasive Spine Total Instrumentation).

25 JULY 2025

Spineway strengthens its international presence with an extensive training program

Spineway, a specialist in innovative implants for the treatment of severe spine disorders, conducted numerous training sessions for surgeons around the world during the first half of 2025. In line with its strategy of international expansion and expertise sharing, the Group organized training courses in Europe, Latin America and Asia, supporting the launch of its product ranges in new markets and consolidating its network of spine surgery professionals.

Press releases

03 JULY 2025

GMED approval for new production line dedicated to ESP prosthèses / First production of LP-ESP intervertebral disc prostheses

Spineway, a specialist in innovative implants for the treatment of severe spine disorders, announces that its subsidiary Spine Innovations has received GMED (French notified body) approval for its new production line dedicated to its LP-ESP and CP-ESP intervertebral disc prostheses. This approval is a significant strategic milestone for the Group, ensuring the manufacturing and supply of its innovative ESP prostheses.

Press releases

06 JUN 2025

Minutes of the General Meeting of June 4, 2025

The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice on Wednesday, June 4, 2025 at 2:00 p.m at the company’s registered office, 7 allée Moulin Berger in Ecully (69).

Press releases

Designed &
manufactured in France
20 years'
experience
Distribution in
more than 50 countries
More than 100,000
associated surgeries

Access to Web Support - Spineway

Access the private area of our website, reserved exclusively for our customers. You will find all the documents related to our products.

Access to download the “My Spineway” application

Discover our application, designed for you. MySpineway gives you access to all our offline documents and more features.

Get it on Google Play Download on the App Store

External redirection

September 9 2020 Launch of MISTI, a modular platform for instruments

Related posts

Spineway strengthens its international presence with an extensive training program

GMED approval for new production line dedicated to ESP prosthèses / First production of LP-ESP intervertebral disc prostheses

Minutes of the General Meeting of June 4, 2025

Access to Web Support - Spineway

Access to download the “My Spineway” application

Intended for healthcare professionals